182 related articles for article (PubMed ID: 16879620)
21. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes.
Bhatia V; Chaudhuri A; Tomar R; Dhindsa S; Ghanim H; Dandona P
Diabetes Care; 2006 Oct; 29(10):2289-94. PubMed ID: 17003308
[TBL] [Abstract][Full Text] [Related]
22. Hypoandrogenaemia is associated with subclinical hypothyroidism in men.
Kumar A; Chaturvedi PK; Mohanty BP
Int J Androl; 2007 Feb; 30(1):14-20. PubMed ID: 16879621
[TBL] [Abstract][Full Text] [Related]
23. Case report: treatment of androgen deficiency in the aging male.
Hernandez A; Baum N
Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
[TBL] [Abstract][Full Text] [Related]
24. Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency.
Giavoli C; Ferrante E; Ermetici F; Bergamaschi S; Ronchi CL; Lania AG; Ambrosi B; Spada A; Beck-Peccoz P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):717-21. PubMed ID: 17121521
[TBL] [Abstract][Full Text] [Related]
25. Primary testicular failure in Klinefelter's syndrome: the use of bivariate luteinizing hormone-testosterone reference charts.
Aksglaede L; Andersson AM; Jørgensen N; Jensen TK; Carlsen E; McLachlan RI; Skakkebaek NE; Petersen JH; Juul A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):276-81. PubMed ID: 17223999
[TBL] [Abstract][Full Text] [Related]
26. Plasma and urinary endothelin-1 concentrations in asphyxiated newborns [corrected].
Tekin N; Dinleyici EC; Aksit MA; Kural N; Erol K
Neuro Endocrinol Lett; 2007 Jun; 28(3):284-8. PubMed ID: 17627263
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
28. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
Ajayi AA; Fidelis P
J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
30. Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years.
Tengstrand B; Carlström K; Hafström I
J Rheumatol; 2009 May; 36(5):887-92. PubMed ID: 19273455
[TBL] [Abstract][Full Text] [Related]
31. Endothelin plasma levels in primary amenorrheic adolescents before and after estrogen treatment.
Creatsas GC; Malamitsi-Puchner AB; Hassan EA; Economou EB; Aravantinos DI
J Soc Gynecol Investig; 1996; 3(6):350-3. PubMed ID: 8923420
[TBL] [Abstract][Full Text] [Related]
32. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.
Khatibi A; Agardh CD; Shakir YA; Nerbrand C; Nyberg P; Lidfeldt J; Samsioe G
Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141
[TBL] [Abstract][Full Text] [Related]
33. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis.
Pache M; Schwarz HA; Kaiser HJ; Wüest P; Klöti M; Dubler B; Flammer J
Med Sci Monit; 2002 Sep; 8(9):CR616-9. PubMed ID: 12218941
[TBL] [Abstract][Full Text] [Related]
34. The role of testosterone replacement therapy following radical prostatectomy.
Khera M; Lipshultz LI
Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
[TBL] [Abstract][Full Text] [Related]
35. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.
He H; Yang F; Liu X; Zeng X; Hu Q; Zhu Q; Tu B
Menopause; 2007; 14(3 Pt 1):385-90. PubMed ID: 17108845
[TBL] [Abstract][Full Text] [Related]
36. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
[TBL] [Abstract][Full Text] [Related]
37. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
Dobs AS
Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
[TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
39. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
[TBL] [Abstract][Full Text] [Related]
40. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
